Skip to main content

Table 3 Applied Measures

From: Interventions supporting cancer patients in making decisions regarding participation in clinical trials - a systematic review

Measures and target measurements

Cassileth Information Styles Questionnaire. Brown (2012) [33]

Self-developed Likert Scale Brown (2012) [33]

Control Preference Scale. Brown (2012) [33], Tattersall (2017/modified) [39] Polite 2019/ modified) [41]

Patient Satisfaction with the Consultation Scale. Brown(2012) [33]

Clinical Trials Attitude Scale Kamen (2018) [40]

Preparation for Decision Making Kamen (2018) [40]

Decisional Conflict Scale Dear (2012) [34] Sundaresan (2017) [38]

Quality of Informed Consent Scale. Hoffner (2012 [35]/ modified); Tattersall (2017) [39] Sundaresan (2017/modified) [38]

Self-developed questionnaire§ Tattersall (2017) [39]

Validated measure

x

 

x

x

 

x

x

x

 

Preference: details (about illness)

 

x

       

Preference: knowledge (of trial)

x

     

x

  

Preference: involvement in decisions

  

x

x

  

x

 

x

Preparedness for decision making(Usefulness of materials)

     

x

   

Satisfaction with decision making

         

Attitude to trials

    

x

 

x

 

x

Satisfaction with provider communication

         

Willingness to participate

      

x

  

Knowledge of trials (purpose of research, expectation of benefits and risks)

      

x

x

 

Self-efficacy

         

Symptoms of anxiety/depression

      

x

 

x

Measures and target measurements

Self-developed survey Kass (2009) [32]

Self-developed questionnaire Hoffner (2012) [35]

Clinical trial questionnaireμ Polite (2019) [41]

Self-developed Likert scales Polite (2019) [41]

Self-developed questionnaire Skovlund (2017) [37]

Self-developed feedback questions Mills (2014) [36]

Decisional Regret Scale±Sundaresan (2017) [38]

Satisfaction with Decision Sundaresan (2017) [38]

Validated measure

      

x

x

Preference: details (about illness)

        

Preference: knowledge (of trial)

        

Preference: involvement in decisions

        

Preparedness for decision making(Usefulness of materials)

 

x

  

x

x

  

Satisfaction with decision making

 

x

  

x

 

x

x

Attitude to trials

   

x

 

x

  

Satisfaction with provider communication

 

x

  

x

   

Willingness to participate

x

  

x

    

Knowledge of trials (purpose of research, expectation of benefits and risks)

x

  

x

x

   

Self-efficacy

   

x

    

Symptoms of anxiety/depression

        
  1. The actual measure could not be retrieved, as the source quoted was a conference paper: WellsKJ, JacobsenPB, QuinnGP, IsleyA, CormanM, SimpsonT. Development and validation of measures of patient perceptions regarding cancer clinical trials. Paper presented at: The American Public Health Association 138th Annual Meeting; 6–10 November, 2010; Denver, Colorado
  2. Elements from: Joffe S, Cook EF, Cleary PD, et al. Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst. 2001;93:139–47
  3. § Elements from: Spielberger State-Trait Anxiety Inventory: ‘Satisfaction with Decision’, ‘Attitudes to RCT Trials Questionnaire. See. Spielberger CD. Manual for the state trait anxiety inventory (form Y). Palo Alto, CA: Consulting Psychologists Press, 1983
  4. Elements from Rodenhuis et al. A qualitative evaluation of patient motives to participate in a phase 1 trial to improve an informed consent procedure.1984
  5. µ  Measure drawn from Jacobsen PB, Wells KJ, Meade CD, et al. Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial. J Clin Oncol. 2012;30: 2516-2521
  6. ± Brehaut JC, O’Connor AM, Wood TJ, et al. Validation of a decision regret scale. Med Decis Making. 2003; 23:281–92
  7. Holmes-Rovner M, Kroll J, Schmitt N, et al. Patient satisfaction with health care decisions: the Satisfaction with Decision scale. Med Decis Making.1996;16:58–64